Intellia-gent Investing, Tesla’s Not-A-Recall & Binance Schminance
Wall Street’s Weird Science ♫ From my heart and from my hand, why don’t people understand … my...
Read MorePosted by Joseph Hargett | Jun 28, 2021 | Great Stuff
Wall Street’s Weird Science ♫ From my heart and from my hand, why don’t people understand … my...
Read MorePosted by Joseph Hargett | Jun 19, 2021 | Great Stuff
What’s The Deal With 23andMe? Great Ones, what do you know about 23andMe (Nasdaq: ME)? Some of you...
Read MorePosted by Joseph Hargett | Jun 8, 2021 | Great Stuff
Biogen: Before I Forget Great Ones, I don’t usually get personal in Great Stuff. But this news on...
Read MorePosted by Steve Fernandez | Jun 8, 2021 | Investment Opportunities, Technology, Winning Investor Daily
One venture capitalist’s decision to specifically target biotech companies suggests the industry presents the highest return potential.
Posted by Charles Mizrahi | May 5, 2021 | American Investor Today, Investment Opportunities, Technology
(4-minute read) You don’t need to be a molecular biologist to understand this technology. It not only saves lives, it could also hand you profits in the years ahead…
Subscribe to our Banyan Edge newsletter to get financial insights and tips from our top investment experts. Start investing with an edge today!
Chief Investment Strategist of Money & Markets
Editor of Precision Profits and Apex Alert
Director of VIP Services
Editor of Strategic Fortunes and three elite services
Editor of Alpha Investor
Director of Investment Research
CEO of Banyan Hill
Research Analyst
“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”
- David G. (Member since 2018)
“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”
- Larry K.
"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"
- Keith S.